Dr. Michael Wacker
InvestorManaging Partner at BioMedPartners
Ingelheim am Rhein, Rhineland-Palatinate, Germany
About
An experienced life science entrepreneur who founded and built vaccine and pharmaceutical companies, including GlycoVaxyn (acquired by GSK for $212M in 2015) and served as chairman of Inositec (acquired by Vifor Pharma). He joined BiomedVC in 2019 and advises startups for Innosuisse with expertise in company building and scientific research.
Experience
- Boehringer IngelheimProduktionstechnologecurrent2025 — presentIngelheim am Rhein, Rhineland-Palatinate, Germany
Education
- Berufsschule Mainz 12025 — 2026
- Walter-Mohr-Realschule TraunreutMittlere Reife2018 — 2024
Skills & more
DatenanalyseSix SigmaProjektmanagement
- Zertifizierter Datenanalyst - deskriptive Datenanalyse in Python — Deggendorf Institute of Technology
- Projektmanager — IHK für München und Oberbayern
- Six Sigma Yellow Belt — Deggendorf Institute of Technology
From Dr.'s professional profile.
Colleagues at BioMedPartners
Aristotelis
Managing Partner at BioMedPartners
Aristotelis Nastos
Managing Partner at BioMedPartners
Claudia Ulbrich
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
Dr. Aristotelis Nastos
Managing Partner at BioMedPartners
Dr. Claudia Ulbrich
Venture Partner at BioMedPartners
Dr. David Urech
Venture Partner at BioMedPartners
Dr. Marianna Feretzaki
Senior Associate at BioMedPartners